|
Q3 2019
Filed on Nov 12, 2019
|
238,248
|
$16.3 - $23.37
$3.88M - $5.57M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
161,877
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
171,557
|
$16.36 - $21.39
$2.81M - $3.67M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,000
|
$263.55 - $303.76
$264K - $304K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
145,188
|
$9.59 - $12.0
$1.39M - $1.74M
|
|
Dicerna Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
188,673
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
97,457
|
$7.38 - $12.25
$719K - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
148,353
|
$10.82 - $14.25
$1.61M - $2.11M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
413,154
|
$17.99 - $26.0
$7.43M - $10.7M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
581,834
|
$1.74 - $2.83
$1.01M - $1.65M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
459,274
|
$0.64 - $0.92
$294K - $423K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
144,209
|
$4.6 - $8.46
$663K - $1.22M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
184,116
|
$3.01 - $6.5
$554K - $1.2M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
246,024
|
$3.57 - $6.58
$878K - $1.62M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
313,209
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
416,260
|
$8.18 - $11.33
$3.41M - $4.72M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
11,000
|
$68.36 - $88.34
$752K - $972K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
150,000
|
$15.73 - $41.6
$2.36M - $6.24M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
110,179
|
$6.89 - $10.45
$759K - $1.15M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
181,000
|
$1.2 - $6.66
$217K - $1.21M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
62,808
|
$9.05 - $12.22
$568K - $768K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
25,837
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
370,958
|
$14.75 - $20.87
$5.47M - $7.74M
|
|
Momenta Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
91,462
|
N/A
|
|
Clementia Pharmaceuticals In
|
Q2 2019
Filed on Aug 12, 2019
|
244,826
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
1,616
|
$130.1 - $139.18
$210K - $225K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
7,400
|
$51.01 - $58.51
$377K - $433K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
5,477
|
$40.69 - $48.46
$223K - $265K
|
|
Audentes Therapeutics Inc
|
Q2 2019
Filed on Aug 12, 2019
|
18,427
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
20,000,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
11,997
|
$1.09 - $3.19
$13.1K - $38.3K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
3,649
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
2,400
|
$219.29 - $241.72
$526K - $580K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
20,000
|
$38.8 - $43.78
$776K - $876K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
100,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
14,400
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
72,606
|
$18.44 - $30.89
$1.34M - $2.24M
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
94,270
|
N/A
|
|
Sunesis Pharmaceuticals Inc
|
Q2 2019
Filed on Aug 12, 2019
|
725,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
4,620
|
$52.09 - $60.3
$241K - $279K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
23,800
|
$34.73 - $40.6
$827K - $966K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
488,992
|
$36.61 - $50.63
$17.9M - $24.8M
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
166,223
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
23,088
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
30,000
|
$17.43 - $28.82
$523K - $865K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
92,221
|
$15.06 - $17.19
$1.39M - $1.59M
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
100,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
4,900
|
$185.47 - $220.11
$909K - $1.08M
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
3,600
|
$46.41 - $66.68
$167K - $240K
|
|
|
Q2 2019
Filed on Aug 12, 2019
|
571,028
|
N/A
|
|